IRCT20130812014333N95RecruitingPhase 2
Effect of electroconvulsive therapy on motor and psychiatric symptoms of drug-resistant Parkinson's patients
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Recruiting
- Enrollment
- 16
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 40 years to 75 years (—)
- Sex
- All
Inclusion Criteria
- •Parkinson's patients with motor and psychiatric symptoms resistant to drug therapy
- •Age between 40 and 75 years
Exclusion Criteria
- •Cardiovascular patients; Patients with cognitive impairment; Patients with the history of seizure, stroke
Investigators
Similar Trials
Recruiting
Not Applicable
ong-Term Effects of Electroconvulsive Therapy on Cognitive FunctioDepression, bipolar disorder, schizophrenia, schizoaffective disorderJPRN-UMIN000047954Keio University50
Completed
Phase 2
Cognitive Effects of Electroconvulsive TherapyCondition 1: major depressive disorder. Condition 2: Schizophrenia. Condition 3: bipolar disorder.Recurrent depressive disorder, Recurrent depressive disorder, current episode severe without psychotic symptoms , Recurrent depressive disorder, current episode severe with psychotic symptomsBipolar affective disorder, Bipolar affective disorder, current episode manic without psychotic symptoms, Bipolar affective disorder, current episode manic with psychotic symptomsF33, F33.2F31, F31.1SchizophreniaIRCT201105246585N1Vice chancellor for research of Shiraz University90
Completed
Not Applicable
ketamine role in depression treatmentMajor Depression.IRCT201104092266N2Isfahan University of Medical Sciences40
Completed
Phase 2
The effect of daily electroconvulsive therapy in patients with refractory schizophreniaSchizophrenia.SchizophreniaIRCT2016090823705N7Vice chancellor for research, Kermanshah University of Medical Sciences14
Completed
Not Applicable
Multimodal Imaging of ECT EffectsMajor Depressive DisorderNCT02871141Charite University, Berlin, Germany68